IL1B and atherosclerosis: In conclusion, targeting signaling pathways such as NF-κB and Notch, along with the specific neutralization of inflammatory cytokines like IL-1β or TNF-α, may provide novel therapeutic strategies to combat inflammation-mediated endothelial dysfunction and EC senescence in the context of atherosclerosis.